What is the recommended dose of itraconazole (antifungal medication) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Itraconazole Dosing in Children

The recommended dose of itraconazole for children is 5 mg/kg/day given in two divided doses (2.5 mg/kg twice daily) for most indications, with treatment doses increased to 10 mg/kg/day in two divided doses for systemic fungal infections. 1

Age-Specific Dosing Considerations

Children ≥2 years of age:

  • Prophylaxis: 2.5 mg/kg twice daily (5 mg/kg/day) 1
  • Treatment of oropharyngeal candidiasis: 2.5 mg/kg twice daily 1
  • Treatment of esophageal candidiasis: 2.5 mg/kg twice daily (5 mg/kg/day), with loading dose of 5 mg/kg twice daily (10 mg/kg/day) on day 1 1
  • Treatment of systemic fungal infections: 5 mg/kg twice daily (10 mg/kg/day) 2
  • Treatment of superficial fungal infections: 5 mg/kg/day for shorter duration 2

Children <2 years of age:

  • May require higher doses due to faster clearance
  • Recent research shows children ≤12 years often need median doses of 6.2 mg/kg/day to achieve therapeutic levels 3
  • 71.4% of children ≤12 years required doses above the recommended 5 mg/kg/day to reach therapeutic levels 3

Formulation Considerations

  • Oral solution (cyclodextrin) is preferred for children and should NOT be used interchangeably with capsules 1
  • Capsules are generally ineffective for treating esophageal disease 1
  • For infants, the oral solution at 5 mg/kg/day provides potentially therapeutic concentrations 4

Therapeutic Drug Monitoring (TDM)

  • TDM is strongly recommended for all children receiving itraconazole 1, 3
  • Target trough concentration: ≥0.5 mg/L 1
  • Samples should be taken at steady state (typically after 5-7 days of therapy) 3
  • Children aged 6 months to 2 years tend to have more frequent low trough concentrations 4

Special Considerations

  • Drug interactions: Use caution when combining with vincristine or other chemotherapeutic agents due to potential for increased toxicity 5
  • Hepatotoxicity: Monitor liver function tests during therapy 3, 5
  • Absorption: Administration with food improves bioavailability
  • Duration of therapy:
    • Superficial fungal infections: 1-8 weeks depending on infection site 6
    • Systemic fungal infections: Based on clinical response and resolution of infection

Common Pitfalls to Avoid

  1. Underdosing in younger children: Children ≤12 years often require higher doses than currently recommended to achieve therapeutic levels 3
  2. Failure to perform TDM: Only 28.6% of courses with subtherapeutic levels had appropriate dose adjustments 3
  3. Inappropriate formulation selection: Itraconazole cyclodextrin oral solution should not be used interchangeably with capsules 1
  4. Overlooking drug interactions: Particularly with chemotherapeutic agents like vincristine 5
  5. Inadequate monitoring: Regular monitoring of liver function is necessary during therapy 3

In conclusion, while the standard recommended dose is 5 mg/kg/day in divided doses, clinicians should be prepared to adjust dosing based on therapeutic drug monitoring, particularly in younger children who often require higher doses to achieve therapeutic levels.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Efficacy and safety of itraconazole use in infants.

World journal of pediatrics : WJP, 2016

Research

Itraconazole Dosing and Drug Monitoring at a Tertiary Children's Hospital.

The Pediatric infectious disease journal, 2019

Research

Itraconazole for invasive fungal infection with pediatric malignancies.

Pediatrics international : official journal of the Japan Pediatric Society, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.